Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VWF antibody (AA 1815-1939)

The Mouse Monoclonal anti-VWF antibody has been validated for WB and IHC (f). It is suitable to detect VWF in samples from Human.
Catalog No. ABIN6938775

Quick Overview for VWF antibody (AA 1815-1939) (ABIN6938775)

Target

See all VWF Antibodies
VWF (Von Willebrand Factor (VWF))

Reactivity

  • 225
  • 44
  • 32
  • 12
  • 7
  • 6
  • 2
  • 1
Human

Host

  • 132
  • 131
  • 13
  • 7
  • 1
  • 1
  • 1
Mouse

Clonality

  • 158
  • 123
  • 2
Monoclonal

Conjugate

  • 133
  • 29
  • 18
  • 11
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This VWF antibody is un-conjugated

Application

  • 188
  • 161
  • 80
  • 74
  • 63
  • 56
  • 49
  • 46
  • 25
  • 16
  • 16
  • 15
  • 9
  • 9
  • 8
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

VWF-1465
  • Binding Specificity

    • 54
    • 22
    • 16
    • 11
    • 9
    • 8
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1815-1939

    Specificity

    Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment of human vWF protein (aa1815-1939) (exact sequence is proprietary)

    Isotype

    IgG1 kappa
  • Application Notes

    Known_Application: Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT) (Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: HUVEC cells. Tonsil.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    VWF (Von Willebrand Factor (VWF))

    Alternative Name

    VWF

    Background

    Coagulation Factor VIII, Factor VIII Related Antigen, F8VWF, von Willebrand Antigen 2, von Willebrand Disease (vWD),von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker)
    Cellular localisation: Cytoplasmic

    Molecular Weight

    250kDa

    Gene ID

    7450, 440848

    UniProt

    P04275
You are here:
Chat with us!